Myocardial damage caused by myocardial ischemia-reperfusion injury (MIRI) is difficult to be alleviated because cardiomyocyte necrosis is an irreversible and unregulated death form. Recently, necroptosis, a necrosis form caused by tumor necrosis factor-α (TNF-α) and Fas ligand (FasL), was found to be regulated by receptor interacting protein 3 (RIP3) and RIP3-receptor interacting protein 1 (RIP1)-mixed lineage kinase domain like protein (MLKL) pathway. But it is unclear whether they also play a regulatory role in MIRI-induced necroptosis. Our previous results showed that in rat MIRI, RIP3 could translocate and express highly in mitochondria. Therefore, it is important to explore proteins that interact with RIP3 which was translocated to mitochondria. The aim of this study was to explore the role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of hypoxia/reoxygenation (H/R). Our results showed that H/R could cause RIP3-depended mitochondrial fragmentation and necrosis-based death; and RIP3-promoted H/R-induced necroptosis in H9c2 cells through increasing lactate dehydrogenase release and inhibiting cell viability. This process did not require RIP1 or MLKL but dynamin-related protein 1 (Drp1), which was related to Drp1 activation, reactive oxygen species elevation, and ΔΨ m decline. This study provides novel insights into the role of RIP3 in cardiomyocyte injury during H/R. RIP3 may serve as a potential target for the treatment of MIRI.
Introduction
Myocardial infarction (MI) following ischemia is a major cause of mortality worldwide [1] . Although early reperfusion is necessary for myocardial salvage, reperfusion itself exacerbates myocardial injury [2] . Therefore, prevention and treatment of myocardial ischemiareperfusion injury (MIRI) are extremely important. MIRI can lead to arrhythmia, cardiomyocyte edema, and MI, which can eventually lead to cardiomyocyte death [3] . Cell death is essential for tissue development and homeostasis maintenance. During the MIRI process, the fate of cardiomyocytes is determined by several different forms of death, namely necrosis, apoptosis, and autophagy [4, 5] . Compared with apoptosis and autophagy, necrosis has traditionally been considered as a random, unregulated, and irreversible death form. Therefore, it is hard to alleviate myocardial damage caused by MIRI through inhibiting cell necrosis.
Recently, researchers found that necrosis induced by tumor necrosis factor-α (TNF-α) and Fas ligand (FasL) could be regulated by precise signaling pathways. This type of necrosis is defined as necroptosis [6, 7] . Its morphological features are cell swelling, mitochondrial dysfunction, and increased cell membrane permeability, etc. Necroptosis is associated with various pathologic changes and organ damage, such as acute pancreatitis [8] , distal colitis [9] , systemic inflammation [10] , and photoreceptor extinction [11] . These pathological processes have a common signaling pathway: RIP3-RIP1-MLKL pathway [12, 13] . In this pathway, receptor interacting protein 3 (RIP3) is thought to serve as a selecting molecular switch that initiates apoptosis or necroptosis. A recent study showed that upregulation of RIP3 could induce cardiomyocyte necroptosis by activating CaMKII rather than RIP1-RIP3-MLKL cascade [14] in doxorubicin-induced myocardial injury. But it is unclear whether this pathway also plays a regulatory role in MIRI-induced necroptosis.
Mitochondria play a major role in regulating cell fate and promote necroptosis through producing necrosis-induced factors after being strongly stimulated by severe pathogenic factors [15, 16] . Therefore, it is crucial to explore the regulating mechanisms of mitochondrial morphology and function in necroptosis caused by MIRI. Numerous studies showed that 'mitochondrial quality control' (MQC) is a major mechanism to maintain mitochondrial function which is relevant to some factors, such as mitochondria-related proteins or enzymes, mitochondrial fission or fusion, the execution of autophagy, and mitochondrial biological processes [17] . Its main mechanisms involve mitochondrial fast-circulation network [18] , mitochondrial cristae morphogenesis [19] , the opening of mPTP [20] , and mitochondrial membrane potential level [21] . Therefore, it is crucial to investigate the regulation of mitochondria and find out certain mitochondria-related proteins that can be regulated by RIP3.
Dynamin-related protein 1 (Drp1), located in cytosol, is a member of large dynamin family with GTPases [22] and essential for noncytokinetic mitochondrial division [23] . Previous studies showed that in vesicular stomatitis, Drp1 was activated and translocated to the outer mitochondrial membrane, which could cause mitochondrial dysfunction through inducing mitochondrial division and increasing reactive oxygen species (ROS) level in the cytoplasm [24] . Through siRNA transfection or gene knockout, the endogenous Drp1 could be suppressed to inhibit mitochondrial division, strengthen mitochondrial network, and delay the open time of mPTP [25] . Furthermore, it has been shown that Drp1 plays an important role in cardiovascular diseases and mitochondrial quality control [26] [27] [28] . However, the role and the exact mechanism of Drp1 in RIP3-promoted necroptosis induced by MIRI remain unclear.
In this study, we demonstrated that RIP3 played a role in the regulation of necroptosis of cardiomyocytes in the process of MIRI, which was independent of RIP1 or MLKL. RIP3, by translocating to mitochondria, interacted with MQC-related protein Drp1 to regulate the structure and function of mitochondria and thus to promote the process of cardiomyocyte necroptosis. This study provides the evidence for further exploring the mechanisms of necroptosis and provides intervention targets for MIRI.
Materials and Methods

Cell culture and treatment
H9c2 cardiac myoblast cell line was obtained from Shanghai Type Culture Collection (Shanghai Institutes for Biological Sciences, Shanghai, China) and cultured in high glucose DMEM (Gibco, Gaithersburg, USA) supplemented with 10% FBS at 37°C, in a fully humidified atmosphere incubator with 5% CO 2 . To induce hypoxia/ reoxygenation (H/R), cells were transferred to a hypoxic incubator in a humidified atmosphere that contained 5% CO 2 and 95% N 2 and cultured in low-glucose DMEM (Gibco). Then the cells were reoxygenated at different time points and incubated in a normal incubator with 5% CO 2 at 37°C.
H9c2 cells were transfected with siRNA-RIP3 (Shanghai Institutes for Genepharmagps, Shanghai, China) using Lipofectamine™ 2000 Transfection Reagent (11668019; Invitrogen, Carlsbad, USA). Prior to transfection, cells were cultured for 24 h. After being diluted in serum-free DMEM, RIP3 siRNA was also mixed with Lipofectamine™ 2000 through pipeting. Cells were incubated for 15-20 min at room temperature, which were then mixed with the Lipofectamine™ 2000/ siRNA mixture. After that, cells were incubated at 37°C in a CO 2 incubator. The transgene expression was analyzed 24-48 h later. RT-qPCR and western blot analysis were then performed to test the interference efficiency. The sequences of siRNA-RIP3 and siRNA-Ctrl were as follows: siRNA-RIP3: 5′-GGCUUCUAAAGCAAGUGAUTT-3′; siRNACtrl: 5′-UUCUCCGAACGUGUCACGUTT-3′.
Western blot analysis
Protein extracts were prepared from H9c2 cells using radioimmunoprecipitation assay (RIPA) buffer (sc-24948; Santa Cruz Biotechnology, Santa Cruz, USA), and cell lysates were cleared by brief centrifugation (12,000 g for 30 min). Protein concentrations in the supernatant were determined by the bicinchoninic acid (BCA) assay. All buffers contained a cocktail of protease inhibitors (Roche, Basel, Switzerland).
Proteins were resolved by 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, USA). After being blocked with 2% bovine serum albumin (BSA) for 2 h, the membrane was incubated overnight at 4°C with various primary antibodies against RIP3 (NBP1-77299; Novus Biological, Littleton, USA), Drp1 (sc-271583; Santa Cruz Biotechnology), RIP1 (sc-7881; Santa Cruz Biotechnology), MLKL (ab183770; Abcam Biotechnology, Cambridge, UK), Phospho-Drp1 (Ser616) antibody (3455S; Cell Signaling Technology, Beverly, USA), Phospho-Drp1 (Ser637) antibody (4867S; Cell Signaling Technology), GAPDH (2118L; Cell Signaling Technology), and VDAC1 (PA1-954A; Thermo Fisher Scientific, Waltham, USA). After incubation with horseradish peroxidase-labeled secondary antibodies (Beyotime Institute of Biotechnology, Shanghai, China) for 1 h at room temperature, ECL kit (Beyotime Institute of Biotechnology) was used to detect signals according to the manufacturer's instructions.
Immunofluorescence analysis
H9c2 cells were cultured on a slide coated with polylysine and fixed with 2% formaldehyde for 30 min prior to detergent extraction with 0.1% Triton X-100 for 20 min at room temperature. The cells were blocked with 2% BSA in phosphate buffered saline (PBS) for 1 h at room temperature, measured by immunofluorescence analysis with primary antibody against Drp1 or RIP3 overnight, and then incubated with Alexa Fluor 488/594-IgG (A11070; A11017; A11072; Invitrogen) for 1 h. Nuclear morphology was analyzed with DAPI staining. Images were collected using a fluorescence microscope (Zeiss, Oberkochen, Germany). For mitochondrial staining, H9c2 cells were incubated with pre-warmed growth medium-containing MitoTracker RedCMXRos (M-7512; Thermo Fisher) for 45 min. Cells were then fixed with 4% formaldehyde for 15 min at 37°C and permeabilized with Triton X100 0.2%. DNA was stained with DAPI.
Isolation of mitochondria
Mitochondria of H9c2 cells were isolated by differential centrifugation using Mitochondria Isolation kit for Cultured Cells (89874; Thermo Fisher). Pellet cells were harvested from cell suspension by centrifuging at 850 g for 2 min. The supernatant was carefully removed and discarded, and Reagent A in the kit was added. The tube was vortexed at medium speed for 5 s and then incubated on ice for exactly 2 min. Reagent B was added and then vortexed the tube at maximum speed for 5 s. Tube was incubated on ice for 5 min and vortexed at maximum speed every minute. Reagent C was added and inverted tube several times. The tube was centrifuged at 700 g for 10 min at 4°C. The supernatant was transferred to a new Eppendorf tube and centrifuged at 12,000 g for 15 min at 4°C. Cytosol fraction was transferred to a new tube. Reagent C was added to the pellet, and centrifuged again at 12,000 g for 5 min. The pellet was the isolated mitochondria. Then the mitochondria were lysed with RIPA buffer at 4°C for 15 min and centrifuged at 12,000 g for 10 min. The supernatant (mitochondrial protein) was transferred to a new tube for further analysis.
Immunoprecipitation analysis
H9c2 cell lysase was prepared as described under the western blot analysis procedure., A total of 10 μl (2 μg) of the appropriate the primary antibodies (RIP3, DRP1, RIP1, and MLKL) and control IgG, together with 50 μl of pretreated agarose conjugate, was added to approximately 200 μg of whole tissue extract, and incubated at 4°C for 30 min. Beads were pelleted by centrifugation at 3000 g for 1 min at 4°C. Then, the supernatant of protein-agarose mixture was transferred to the antibody-beads mixture (with supernatant removed), and then incubated at 4°C overnight. Pellet was collected by centrifugation at 3000 g for 1 min at 4°C. The supernatant was carefully aspirated and discarded. The pellet was washed 8-10 times with RIPA buffer, by repeating the centrifugation step each time. After the final wash, the supernatant was aspirated and discarded, and the pellet was resuspended in 30 μl of 5× SDS and boiled for 5 min. After centrifugation at 15,000 g for 5 min at 4°C, the sample was subject to western blot analysis.
Lactate dehydrogenase release assay and cell viability assay
A commercial test kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was used to measure the amount of lactate dehydrogenase (LDH) release. The viability of H9c2 cells was determined using CCK-8 assay (Beyotime Institute of Biotechnology). The procedures were the same as what were described in our previously published report [20] .
Mitochondrial membrane potential assay
To measure the depolarization of mitochondrial membrane, H9c2 cells were stained with JC-1 probe. Briefly, the treated cells were incubated with JC-1 staining solution (5 μg/ml; Beyotime Institute of Biotechnology) at 37°C for 20 min and rinsed twice with staining buffer. ΔΨ m values were monitored by determining the relative amounts or dual emissions from both mitochondrial JC-1 monomers and aggregates, using a fluorescent microscope (Nikon, Tokyo, Japan). In healthy mitochondria with high potential, JC-1 formed complexes known as J-aggregates with red fluorescence. Mitochondria with low potential, JC-1 remained in the monomeric form, which exhibits green fluorescence. JC-1 exhibited potential-dependent accumulation in mitochondria, indicated by a fluorescence emission change from green to red. Mitochondrial depolarization was indicated by an increase in the ratio of green/red fluorescence intensity using Image J densitometric analysis.
Measurement of the intracellular ROS level
The intracellular level of ROS was detected using the redox-sensitive fluorescent dye, DCFH-DA. Briefly, the culture medium was removed and the cells were washed three times with PBS. The cells were incubated with DCFH-DA (10 μM) which was diluted with serum-free medium at 37°C during the last 20 min. The cells were then washed five times with PBS and the relative amount of fluorescent product was captured using a fluorescence microscope connected to an imaging system (BX50-FLA; Olympus, Tokyo, Japan).
ImageJ software was used to analyze the mean fluorescence intensity (MFI) of DCFH-DA, which indirectly showed the level of cell ROS. The experiment was repeated five times. 
Statistical analysis
Data were presented as the mean ± standard deviation (SD) and compared by one-way analysis of variance. A P-value <0.05 was considered of statistically significant difference.
Results
Identification of siRNA-RIP3 interference efficiency siRNA against RIP3 was used to inhibit RIP3 expression in H9c2 cardiomyocytes. RT-qPCR and western blot analysis were performed to test the interference efficiency. Results showed that the efficiency of siRNA-mediated inhibition of RIP3 expression in rat H9c2 cardiomyocytes was higher than 70%, while siRNA-Ctrl had no obvious interference on the expression of RIP3 (Fig. 1) . These results suggested that siRNA-RIP3 could be used for subsequent studies.
H/R could induce increased expression of RIP3 in H9c2 cardiomyocytes and cause RIP3-promoted cardiomyocyte damage
Previous studies have shown that RIP3 serves as a determinant and molecular switch to participate in the process of necroptosis [8] , therefore the expression level of RIP3 was detected in H9c2 cells at different reoxygenation time intervals (2, 4, 6, and 8 h) after 30 min of hypoxia. Results showed that compared with the normal oxygenation (Ctrl) group, the expression level of RIP3 in H9c2 cells was increased significantly after 2, 4, 6, and 8 h of reoxygenation and was increased most significantly after 4 h of reoxygenation ( Fig. 2A) . H/R could induce the death of H9c2 cells, which was based on the following two points. The cell viability in H/R group was significantly reduced as revealed by CCK-8 assay (Fig. 2B) and the cell membrane integrity was also decreased as indicated by a significant increase of LDH release (Fig. 2C) . Compared with the Ctrl group, H/ R could significantly reduce the cell viability of the RIP3 normalexpression (siRNA-Ctrl) group and the RIP3 interfering (siRNA-RIP3) group, and increase the content of LDH. When compared with the siRNA-Ctrl+H/R group, the cardiomyocyte cell viability was significantly increased in the siRNA-RIP3+H/R group (Fig. 2D) and the amount of LDH released was significantly reduced (Fig. 2E ). These results suggested that H/R could cause severe cardiomyocyte damage. This process required the involvement of RIP3. Based on the above results, in our subsequent experiments, 4 h of reoxygenation after 30 min hypoxia was used as the H/R H9c2 cell model.
H/R could cause RIP3-dependent mitochondrial damage and necrosis
Maintaining the mitochondrial integrity is considered to be a determinant to keep cardiomyocyte viability. So it is important to investigate the regulation mechanisms of mitochondrial morphology and function. First, we analyzed the morphological changes of H9c2 cells. The mitochondrial marker (MitoTracker™ Red CMXRos) was added to H9c2 cell culture medium. Compared with their respective control groups, mitochondrial fragmentation in the siRNA-Ctrl+H/R group was very significant, and it was almost nonexistent in the siRNA-RIP3+H/R group. These results suggested that H/R could cause RIP3-dependent mitochondrial fragmentation (Fig. 3A) . Severe mitochondrial fragmentation could lead to cardiomyocyte death. Both necrosis and apoptosis are the cardiomyocytic death forms induced by H/R, but it is unclear which is the major one during MIRI. Z-VAD-FMK, a pan-caspase inhibitor, was used to inhibit apoptosis, suppress caspase cracking role in RIP3 and enhance RIP3's function. Hoechst-PI staining was used to detect apoptotic-necrosis of H9c2 cardiomyocytes. The results showed that the cell apoptosis was inhibited while the necrosis was enhanced. H/R-induced cardiomyocyte death was mainly RIP3-regulated necrosis (Fig. 3B ). These results suggested that H/R could cause RIP3-dependent mitochondrial damage and necrosis in H9c2 cardiomyocytes.
RIP3-induced cardiomyocyte necrosis did not require RIP1 or MLKL
The aforementioned results suggested that H/R could significantly increase the expression of RIP3 protein. Some recent studies have shown that RIP3/RIP1 necrosis pathway plays a key role in the necroptosis caused by some diseases [9] , and MLKL has been proved to be a component of necrosome [12] . Thus, we next focused on whether these two molecules participate in RIP3-mediated necroptosis of cardiomyocytes. The binding of RIP3 with RIP1 and MLKL was revealed by immunoprecipitation experiments. The results showed that RIP3 was hardly associated with RIP1 or MLKL (Fig. 4A) . Western blot analysis results showed that H/R promoted the translocation of RIP3 to mitochondria and its expression in mitochondria was significantly increased, whereas RIP1 and MLKL were hardly translocated to the mitochondria (Fig. 4B) . These results suggested that RIP3-induced cardiomyocyte necrosis did not require RIP1 or MLKL.
Drp1 was required in cardiomyocyte necroptosis induced by RIP3
Mitochondrion has been emerged as a primary cellular target in efforts to alleviate lethal I/R injury [29] . The maintenance of mitochondrial integrity has been recognized as a determinant of cardiomyocyte viability, which is related to MQC. The MQC cycle involves a dynamic process of fission, fusion, mitophagy, and biogenesis. So we next investigated whether Drp1, a mediator of fission, plays a role in RIP3-induced cardiomyocyte necroptosis. First, the results of immunoprecipitation suggested that H/R could increase the binding of RIP3 with Drp1 in mitochondrial protein (Fig. 5A) . The results of immunofluorescence microscopy showed that the localization of RIP3 and Drp1 was significantly increased in H9c2 cells after H/R (Fig. 5B) , which was consistent with the result of immunoprecipitation. Expression of Drp1 was detected by western blot analysis in siRNA-Ctrl group and siRNA-RIP3 group. These results showed that the expression of Drp1 was significantly increased in H/R-induced siRNA-Ctrl cardiomyocytes and decreased in H/R-induced siRNA-RIP3 cardiomyocytes. This expression trend was consistent with that of RIP3 (Fig. 5C) . Western blot analysis of the translocation of RIP3 and Drp1 from cytoplasm to mitochondrion in H9c2 cardiomyocytes showed that H/R could cause RIP3 and Drp1 translocation from cytoplasm to mitochondrion with increased expressions (Fig. 5D) . These results indicated that Drp1 was required for RIP3-induced cardiomyocyte necroptosis.
RIP3-induced cardiomyocyte necroptosis was related to Drp1 activation, ROS elevation and ΔΨ m decline
Previous studies showed that activation of Drp1 was a cause-andeffect factor in numerous cardiac diseases, including MI [30] , myocardial hypertrophy [31] , and heart failure [32] . However, whether Drp1's activation plays a role in MIRI is unknown. It has been reported that phosphorylation and dephosphorylation of Drp1 determine its intracellular distribution and GTPase activity [33] . Phosphorylation of Drp1 at position ser637 (p-Drpl-ser637) can inhibit Drp1 activity and reduce its translocation to mitochondria, whereas the phosphorylation at position ser616 of Drpl (p-Drp1-ser616) promotes Drpl-mediated mitochondrial division [34, 35] . To explore how RIP3 activates Drp1 and induces its expression during irreversible MIRI, we used specific antibodies that could recognize phosphorylation at Drp1 ser616 or ser637. Western blot analysis showed that H/R could induce a significant increase in p-Drplser616 expression and a significant decrease in p-Drp1-ser637 of the RIP3 normal-expression group and reversed after RIP3 expression was interfered (Fig. 6A,B) . These results indicated that RIP3 was essential during H/R-induced Drp1 activation.
Mitochondrial dynamic disruption may be caused by excessive oxidative stresses, eventually leading to mitochondrial dysfunction [36] . Therefore, ROS assay kit was used to examine whether H/R and RIP3 could affect ROS production in cardiomyocytes. Our results showed that in the siRNA-Ctrl group, H/R could increase the production of ROS, and the opposite change occurred after RIP3 was interferenced, suggesting that H/R could increase the production of ROS and this process required the presence of RIP3 (Fig. 6C) . Increased production of ROS was associated with increased expression of Drp1, which could promote mitochondrial division and reduce mitochondrial calcium stores. Thus, we next examined changes in mitochondrial inner membrane potential (ΔΨ m ), a parameter that reflects mitochondrial function, by quantitatively detecting the fluorescence intensity of JC-1. Our results showed that H/R promoted RIP3-dependent ΔΨ m decrease in H9c2 cardiomyocytes (Fig. 6D) .
These data indicated that the detrimental effects of RIP3 were mediated, at least in part, by phosphorylating Drp1 and linking H/ R-evoked ROS to Drp1 activation. Drp1 could cause ΔΨ m decline and participate in RIP3-induced necroptosis.
Discussion
MIRI is common in cardiac transplantation, coronary artery bypass graft surgery, and MI. Although some clinical control measures, such as thrombolytic therapy, hypothermia, cessation, and thrombolysis have some therapeutic effects, it is quite difficult to reduce prolonged ischemia and severe reperfusion injury. How to mobilize the endogenous protective mechanisms of cardiomyocytes to relieve or prevent MIRI has recently gained great concern.
MIRI can lead to arrhythmia, cardiomyocyte edema, and MI, which will eventually lead to cardiomyocyte death. However, it is unclear which one is the predominant death form in MIRI. H/R is a condition mimicking I/R in vitro cultured cardiomyocytes. First, by using the pan-caspase inhibitor Z-VAD-FMK and Apoptosis-Necrosis assay kits, we found that H/R-induced cell death was mainly necrosis.
Necroptosis is a regulated, procedural, necrotic pathway which has the same morphological features as unregulated necrosis [37] . RIP3 is a specific factor that regulates necroptosis and a molecular switch that mediates the switch from apoptosis to necroptosis. Results showed that the expression level of RIP3 was increased in the H/R-treated H9c2 cardiomyocyte model. Cell viability assay and LDH release assay showed that increased RIP3 expression could reduce the integrity of cardiomyocyte and promote its death. It was also found that inhibition of RIP3 expression could significantly attenuate cell damage caused by H/R.
Increasing attentions on necroptosis are largely due to its pathological and physiological importance. RIP3-mediated necroptosis has been proven to be involved in photoreceptor cell loss [38] , skin inflammation, and lymphoproliferative diseases [39] . Pathological processes mentioned above have a common pathway: the RIP3-RIP1-MLKL pathway [40] [41] [42] . However, whether this pathway is conserved in MIRI is still unclear. As the function of proteins was determined by their intracellular translocation, subcellular localization, and mutual interactions, we analyzed the participation and function of this reported necroptotic axis using immunoprecipitation assays and western blot analysis. Our results showed that RIP3 was hardly associated with RIP1 or MLKL in cytoplasmic protein during H/R. Western blot analysis showed that H/R could promote RIP3 translocation to mitochondrion with an increased expression, whereas RIP1 and MLKL were hardly translocated to the mitochondria. These results suggested that RIP3-induced cardiomyocyte necroptosis did not require RIP1 or MLKL.
Maintaining mitochondrial integrity is considered to be a determinant for cardiomyocyte viability. Therefore, it is essential to explore the regulating mechanisms of mitochondrial morphology and function in MIRI. The mitochondrial marker was added to label cardiomyocyte mitochondria and the results showed that H/R could cause RIP3-dependent mitochondrial fragmentation. Severe mitochondrial damage could eventually cause cardiomyocytes death.
In previous studies, specific mechanisms of mitochondrial morphology and structural changes in apoptosis have been studied and analyzed in detail [43, 44] . But its role in necrosis has been neglected. According to our previous study, RIP3 could translocate to mitochondria and express highly. H/R could cause mitochondrial fractured in cardiomyocytes. So reducing or reversing mitochondrial structure damage may have a protective effect. Numerous studies have shown that normal physiological function of mitochondria can be preserved by a process called MQC [45, 46] , which plays an indispensable role in numerous diseases [47, 48] . So we also focused on exploring the relationship between cardiomyocyte necroptosis and MQC-related proteins.
Drp1, a member of the dynamin family of large GTPases [22] , is a primary cytoplasmic protein related to mitochondrial fission [49] . When Drp1 is activated, it can form ring-like multimers and translocate to the mitochondria, where, in concert with accessory proteins, Drp1 facilitates mitochondrial division [50] . Much evidence has confirmed that Drp1 contributes to cell death [51, 52] . Malfunctions of Drp1 have been increasingly implicated in human diseases such as neurodegenerative and inflammatory disorders. But Drp1's specific role in MIRI is still unclear. Our results showed that the expression tendency of Drp1 was consistent with that of RIP3. Notably, H/R treatment dramatically increased the co-localization of RIP3 and Drp1. Western blot analysis showed that both RIP3 and Drp1 were translocated from cytosol to mitochondrion, with their increased expressions in H/R H9c2 cells. These in vitro data from cardiomyocytes indicated that Drp1 was required in cardiomyocyte necroptosis induced by RIP3.
Phosphorylation and dephosphorylation of Drpl have been reported to determine its intracellular distribution and GTPase activity [53] . To confirm how RIP3 activates Drp1 and induces its expression during irreversible cardiomyocyte injury, we used some specific antibodies that specifically recognized phosphorylation at Drp1 ser616 and ser637. Western blot analysis showed that H/R could induce a significant increase in p-Drpl-ser616 expression and a significant decrease in p-Drp1-ser637 expression of the siRNACtrl group and reversed after RIP3 expression was interfered. These results indicated that RIP3 was indispensable for H/R-induced Drp1 activation.
Hyper-responsive oxidative stress may cause mitochondrial dynamic disorder. By detecting the fluorescence intensity of DCF, it can help to assess intracellular ROS levels. Our results showed that H/R could increase ROS production in cardiomyocytes, and this process required the presence of RIP3. Previous studies have shown that mPTP opening can cause a decrease of ΔΨ m , which subsequently causes mitochondrial swelling, outer membrane breakage, and eventually leads to pro-apoptotic proteins' release from mitochondria to cytoplasm [54] . Therefore, we examined the change of ΔΨ m by using the fluorescent probe JC-1. The results showed that H/R could decrease the ΔΨ m of H9c2 cells. The specific mechanism of this process might be that H/R can increase Drp1 expression and accelerate mitochondrial fission, resulting in a large number of fragmented mitochondria and ROS, and then promotes the 'ROS induces ROS release' [55] . In addition, Drp1 can reduce mitochondrial calcium reserve to enhance cells' susceptibility to mitochondrial permeability transition. These mechanisms can amplify the damage caused by excessive production of oxygen free radicals [56] and decrease the ΔΨ m . These results showed that RIP3 were mediated, at least in part, by phosphorylating Drp1 and linking H/R-evoked ROS to Drp1 activation. Drp1 could cause ΔΨ m decline and participate in RIP3-induced necroptosis. However, the precise mechanisms and downstream necrosis steps are yet to be defined in future studies.
In summary, we demonstrated that RIP3 plays a role in the regulation of necroptosis of cardiomyocytes in the process of myocardial I/R, which is independent of RIP1 or MLKL. RIP3, by translocating 
